✦ LIBER ✦

B cell therapy with the anti-CD22 monoclonal antibody epratuzumab: Comment on the editorial by St.Clair and Tedder

✍ Scribed by David M. Goldenberg; Rhona Stein; John P. Leonard; Serge D. Steinfeld; Thomas Dörner; Gerd R. Burmester

Book ID: 101648747
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 34 KB
Volume: 54
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.21937

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The advantage of residualizing radiolabe

The advantage of residualizing radiolabels for targeting B-cell lymphomas with a radiolabeled anti-CD22 monoclonal antibody

✍ M. Jules Mattes; Lisa B. Shih; Serengulam V. Govindan; Robert M. Sharkey; Gaik L 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 104 KB

CD22 antibodies (Abs) bound to B-cell lymphomas are known to be internalized and catabolized rapidly. Therefore, it would be expected that use of CD22 as a target for radioimmunotherapy should be enhanced by the use of "residualizing" radiolabels, which are trapped within the cell after catabolism o

Palliative therapy of giant basal cell c

Palliative therapy of giant basal cell carcinoma with the monoclonal anti-epidermal growth factor receptor antibody cetuximab

✍ H. Müller; K. Eisendle; G. Gastl; R. Höpfl; B. Zelger 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 337 KB

Anti–cyclic citrullinated peptide antibo

Anti–cyclic citrullinated peptide antibody in early rheumatoid arthritis: Comment on the editorial by Scott

✍ Walther J. van Venrooij; Leo B. A. van de Putte; Frank H. J. van den Hoogen 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 32 KB 👁 2 views

Morbidity not increased in rheumatoid ar

Morbidity not increased in rheumatoid arthritis patient with profound lymphopenia following CD4 monoclonal antibody therapy: Comment on the article by Isaacs et al

✍ Yamini Menon; Ranju Singh; Raquel Cuchacovich; Luis R. Espinoza 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 523 KB

Diffuse large B-cell lymphoma on the bac

Diffuse large B-cell lymphoma on the back of a patient with AIDS: Successful treatment by the CD20 monoclonal antibody rituximab

✍ Constanze Voigtländer; Thomas Harrer; Lothar Schneider; Hendrik Schulze-Koops; G 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

Experimental treatment of human diffuse

Experimental treatment of human diffuse large B-cell lymphoma xenografts by doxycycline alone or in combination with the anti-CD20 chimeric monoclonal antibody rituximab

✍ Franck Assayag; Nicole Brousse; Jérôme Couturier; Elizabeth Macintyre; Claire Ma 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB 👁 2 views